BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Insani WN, Whittlesea C, Alwafi H, Man KKC, Chapman S, Wei L. Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis. PLoS One 2021;16:e0252161. [PMID: 34038474 DOI: 10.1371/journal.pone.0252161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Budakoğlu Iİ, Coşkun Ö, Kıyak YS, Uluoğlu C. Teaching rational prescribing in undergraduate medical education: a systematic search and review. Eur J Clin Pharmacol 2023. [PMID: 36622428 DOI: 10.1007/s00228-022-03448-2] [Reference Citation Analysis]
2 Murphy RM, Klopotowska JE, de Keizer NF, Jager KJ, Leopold JH, Dongelmans DA, Abu-Hanna A, Schut MC. Adverse drug event detection using natural language processing: A scoping review of supervised learning methods. PLoS One 2023;18:e0279842. [PMID: 36595517 DOI: 10.1371/journal.pone.0279842] [Reference Citation Analysis]
3 Dubin I, Schattner A. Extreme iatrogenesis. QJM 2022;115:864-5. [PMID: 35961030 DOI: 10.1093/qjmed/hcac197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Choi E, Kim S, Suh HS. Exploring the prevalence and characteristics of adverse drug events among older adults in South Korea using a national health insurance database. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1047387] [Reference Citation Analysis]
5 Rochanathimoke O, Tragulpiankit P, Turongkaravee S, Jittikoon J, Udomsinprasert W, Chaikledkeaw U. Costs Associated with Adverse Drug Reactions Among HIV/TB Patients in Thailand. Clinicoecon Outcomes Res 2022;14:587-99. [PMID: 36105845 DOI: 10.2147/CEOR.S373489] [Reference Citation Analysis]
6 Galai E, Scotti L, Gilardetti M, Ucciero A, Ferrante D, Poluzzi E, Genazzani AA, Barone-Adesi F. Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study. Int J Environ Res Public Health 2022;19:7353. [PMID: 35742605 DOI: 10.3390/ijerph19127353] [Reference Citation Analysis]
7 Susilo R, Diantini A, Lukman K, Perwitasari DA, Kunaedi A. Translation and Validation of the Indonesian Version of the Adverse Drug Reaction Severity Level Instruments in Colorectal Cancer Patients. JMDH 2022;Volume 15:1153-61. [DOI: 10.2147/jmdh.s353325] [Reference Citation Analysis]
8 Logan V, Bamsey A, Carter N, Hughes D, Turner A, Jordan S. Clinical Impact of Implementing a Nurse-Led Adverse Drug Reaction Profile in Older Adults Prescribed Multiple Medicines in UK Primary Care: A Study Protocol for a Cluster-Randomised Controlled Trial. Pharmacy 2022;10:52. [DOI: 10.3390/pharmacy10030052] [Reference Citation Analysis]
9 Neuner-Jehle S, Senn O. Polypharmazie. Praxis (Bern 1994) 2022;111:168-73. [PMID: 35232259 DOI: 10.1024/1661-8157/a003824] [Reference Citation Analysis]
10 Rachamin Y, Jäger L, Meier R, Grischott T, Senn O, Burgstaller JM, Markun S. Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice—A Cross-Sectional Database Study. Front Pharmacol 2022;13:832994. [DOI: 10.3389/fphar.2022.832994] [Reference Citation Analysis]
11 Tiguman GMB, Biase TMMA, Silva MT, Galvão TF. Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019. Epidemiol Serv Saude 2022;31:e2021653. [PMID: 35730815 DOI: 10.1590/S2237-96222022000200003] [Reference Citation Analysis]
12 Mousavi T, Abdollahi M. Comparative regulatory testing requirements. Reference Module in Biomedical Sciences 2022. [DOI: 10.1016/b978-0-12-824315-2.00040-3] [Reference Citation Analysis]
13 Lim R, Ellett LK, Roughead EE, Cheah PY, Masnoon N. Patient-Reported Questionnaires to Identify Adverse Drug Reactions: A Systematic Review. Int J Environ Res Public Health 2021;18:11877. [PMID: 34831635 DOI: 10.3390/ijerph182211877] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Khan Z, Karatas Y, Martins MAP, Jamshed S, Rahman H. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review. Curr Med Res Opin 2021;:1-10. [PMID: 34694167 DOI: 10.1080/03007995.2021.1997287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kell DB. The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes. Molecules 2021;26:5629. [PMID: 34577099 DOI: 10.3390/molecules26185629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Serra López-Matencio JM, Gómez M, Vicente-Rabaneda EF, González-Gay MA, Ancochea J, Castañeda S. Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic. Pharmaceuticals (Basel) 2021;14:819. [PMID: 34451916 DOI: 10.3390/ph14080819] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]